Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1999, p. 1289-1290, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Correlation between In Vitro Susceptibility Determined by E Test
and Response to Therapy with Amphotericin B: Results from a Multicenter
Prospective Study of Candidemia
Cornelius J.
Clancy and
M. Hong
Nguyen*
Department of Medicine, Division of
Infectious Diseases, University of Florida College of Medicine, and
VA Medical Center, Gainesville, Florida
Received 8 July 1998/Returned for modification 8 October
1998/Accepted 11 March 1999
Ninety-nine Candida bloodstream isolates underwent
testing for susceptibility to amphotericin B by the E test, and the
results were correlated with patients' responses to amphotericin B. The MICs for isolates that were associated with therapeutic failure were significantly higher than the MICs for those associated with therapeutic success. A MIC of
0.38 µg/ml identified isolates likely
to be associated with therapeutic failure.
*
Corresponding author. Mailing address: University of
Florida College of Medicine, Department of Medicine, Division of
Infectious Diseases, P.O. Box 100277, JHMHC, Gainesville, FL 32610. Phone: (352) 392-4058. Fax: (352) 392-6481. E-mail:
nguyemt{at}medicine.ufl.edu.
Antimicrobial Agents and Chemotherapy, May 1999, p. 1289-1290, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pfaller, M. A., Diekema, D. J.
(2007). Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clin. Microbiol. Rev.
20: 133-163
[Abstract]
[Full Text]
-
Park, B. J., Arthington-Skaggs, B. A., Hajjeh, R. A., Iqbal, N., Ciblak, M. A., Lee-Yang, W., Hairston, M. D., Phelan, M., Plikaytis, B. D., Sofair, A. N., Harrison, L. H., Fridkin, S. K., Warnock, D. W.
(2006). Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.. Antimicrob. Agents Chemother.
50: 1287-1292
[Abstract]
[Full Text]
-
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., Benjamin, L. E., Thomson Sanza, L., Huie, S., Yeo, S. F., Brandt, M. E., Warnock, D. W.
(2004). Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program. J. Clin. Microbiol.
42: 1519-1527
[Abstract]
[Full Text]
-
Espinel-Ingroff, A.
(2003). Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991). J. Clin. Microbiol.
41: 403-409
[Abstract]
[Full Text]
-
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Verweij, P. E.
(2002). Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus Species. J. Clin. Microbiol.
40: 2876-2885
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Rezusta, A.
(2002). E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. J. Clin. Microbiol.
40: 2101-2107
[Abstract]
[Full Text]
-
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W.
(2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev.
14: 643-658
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., The SENTRY Participant Group,
(2001). International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J. Clin. Microbiol.
39: 3254-3259
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J.
(2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother.
45: 1828-1835
[Abstract]
[Full Text]
-
Espinel-Ingroff, A.
(2001). Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi. J. Clin. Microbiol.
39: 1360-1367
[Abstract]
[Full Text]
-
Peyron, F., Favel, A., Michel-Nguyen, A., Gilly, M., Regli, P., Bolmström, A.
(2001). Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest. J. Clin. Microbiol.
39: 339-342
[Abstract]
[Full Text]
-
Polacheck, I., Strahilevitz, J., Sullivan, D., Donnelly, S., Salkin, I. F., Coleman, D. C.
(2000). Recovery of Candida dubliniensis from Non-Human Immunodeficiency Virus-Infected Patients in Israel. J. Clin. Microbiol.
38: 170-174
[Abstract]
[Full Text]